Yongheng Shu
Cancer Center And State Key Laboratory Of Biotherapy
Chengdu, China
Chengdu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Expression of SIRPα-Fc by oncolytic virus enhances antitumor efficacy through tumor microenvironment reprogramming.
Journal: Frontiers in immunology
Published: October 18, 2024
Live-attenuated Japanese encephalitis virus inhibits glioblastoma growth and elicits potent antitumor immunity.
Journal: Frontiers in immunology
Published: June 30, 2022
In Situ Tumor Vaccine Expressing Anti-CD47 Antibody Enhances Antitumor Immunity.
Journal: Frontiers in oncology
Published: March 16, 2022
Long noncoding RNA RP11-241J12.3 targeting pyruvate carboxylase promotes hepatocellular carcinoma aggressiveness by disrupting pyruvate metabolism and the DNA mismatch repair system.
Journal: Molecular biomedicine
Published: August 08, 2021
Engineered exosome-like nanovesicles suppress tumor growth by reprogramming tumor microenvironment and promoting tumor ferroptosis.
Journal: Acta biomaterialia
Published: May 11, 2021
High-dose VitC plus oncolytic adenoviruses enhance immunogenic tumor cell death and reprogram tumor immune microenvironment.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: March 01, 2021
Targeting tumor-associated macrophages for cancer immunotherapy.
Journal: Biochimica et biophysica acta. Reviews on cancer
Published: May 11, 2020
The Effect of Residual Triton X-100 on Structural Stability and Infection Activity of Adenovirus Particles.
Journal: Molecular therapy. Methods & clinical development
Published: March 27, 2020
A novel method to purify adenovirus based on increasing salt concentrations in buffer.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: June 10, 2019
Showing 1-10 of 10
Last Updated: 09/26/2026